| Followers | 17 |
| Posts | 5012 |
| Boards Moderated | 0 |
| Alias Born | 04/13/2016 |
Tuesday, March 10, 2020 10:18:57 AM
Trying to keep the evil genie in the bottle.
Coronavirus is about 30 times more lethal than the flu, according to the best estimates available at this moment. However, if it becomes more established, it will likely decline in mortality and be seen as another noxious virus.
What governments were hoping to accomplish was to contain the virus so it would literally die out. I don’t think that will happen at this point. There are simply too many people infected now.
Once covid-19 sweeps through countries, the 30-fold difference in mortality will become apparent. Lots of people get flu shots, but no one gets a covid-19 shot. That means less herd immunity and a faster and more widespread rate of infection.
The second phase will be efforts to slow the transmission while a vaccine is developed. Vaccine development will take another 12 to 18 months, but the vaccine will be a great help if we can keep the virus from widely spreading before then. My guess is our chances of that are low, but not impossible. All of the actions to minimize community transmission will affect certain sectors of the economy heavily. Sporting events, tourist travel, movies, and the like will be impacted. This has secondary effects on the energy industry and so on.
Once the initial sweep of the virus passes through the country, survivors will be less likely to die, meaning the mortality drops next year by a large factor, aided by the vaccine.
Until then, epidemiologists and Wall Street are concerned about that 30-fold difference in mortality and the risks of widespread community transmission. Like KBLB, it’s hard to predict what will happen with any certainty.
Coronavirus is about 30 times more lethal than the flu, according to the best estimates available at this moment. However, if it becomes more established, it will likely decline in mortality and be seen as another noxious virus.
What governments were hoping to accomplish was to contain the virus so it would literally die out. I don’t think that will happen at this point. There are simply too many people infected now.
Once covid-19 sweeps through countries, the 30-fold difference in mortality will become apparent. Lots of people get flu shots, but no one gets a covid-19 shot. That means less herd immunity and a faster and more widespread rate of infection.
The second phase will be efforts to slow the transmission while a vaccine is developed. Vaccine development will take another 12 to 18 months, but the vaccine will be a great help if we can keep the virus from widely spreading before then. My guess is our chances of that are low, but not impossible. All of the actions to minimize community transmission will affect certain sectors of the economy heavily. Sporting events, tourist travel, movies, and the like will be impacted. This has secondary effects on the energy industry and so on.
Once the initial sweep of the virus passes through the country, survivors will be less likely to die, meaning the mortality drops next year by a large factor, aided by the vaccine.
Until then, epidemiologists and Wall Street are concerned about that 30-fold difference in mortality and the risks of widespread community transmission. Like KBLB, it’s hard to predict what will happen with any certainty.
Recent KBLB News
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/21/2026 06:41:52 PM
- Kraig Biocraft Laboratories Advances Record Production and Begins Processing 1.8 Metric Tons of Recombinant Spider Silk Cocoons • GlobeNewswire Inc. • 04/20/2026 11:05:00 AM
- The End of Performance at Any Cost, as Spider Silk Points to a Cleaner Future • GlobeNewswire Inc. • 04/15/2026 01:15:00 PM
- Advanced Materials Science 2026: How Spider Silk, Carbon Fiber & Aerogels are Powering Medicine, Defense & Space Tech Today • GlobeNewswire Inc. • 04/14/2026 01:20:00 PM
- From Milestone to Momentum: Kraig Biocraft Leadership Travels to South East Asia Following Record-Setting 1.3 Metric Ton Recombinant Spider Silk Cocoon Production Cycle • GlobeNewswire Inc. • 04/13/2026 11:05:00 AM
- From Genetic Puzzle to Industrial Platform • GlobeNewswire Inc. • 04/08/2026 01:31:34 PM
- Why Advanced Materials Are Reshaping the Industrial Ecosystem • GlobeNewswire Inc. • 04/07/2026 01:15:00 PM
- The intersection of biotechnology, advanced materials, and molecular biology • IH Market News • 04/07/2026 06:56:44 AM
- Spider Silk Has Been a Lab Curiosity for Decades; One Company Just Produced Over a Ton of It in a Single Month • AllPennyStocks.com • 04/06/2026 05:06:15 PM
- Kraig Biocraft Laboratories Shatters Production Record, Delivering Over 1.3 Metric Tons of Spider Silk Cocoons in a Single Month, A 5X Increase Over Previous High • GlobeNewswire Inc. • 04/06/2026 11:05:00 AM
- From Lab Fiber to Luxury Fabric: Kraig Biocraft Laboratories Targets Apparel First with Engineered Spider Silk • GlobeNewswire Inc. • 04/02/2026 01:05:00 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/30/2026 09:38:14 PM
- Kraig Biocraft Laboratories Deploys Over 700,000 BAM-1 Alpha Production Hybrids, Achieving Key Milestone in its Aggressive Scale-Up Plan • GlobeNewswire Inc. • 03/30/2026 11:05:00 AM
- Kraig Biocraft Laboratories Increases R&D Capacity, as Project Atlas Breakthroughs Creating New Spider Silk Transgenics • GlobeNewswire Inc. • 03/23/2026 11:05:00 AM
- Engineered Silkworms Spin Spider Silk as Biotech Firm Targets Commercial Scale • GlobeNewswire Inc. • 03/18/2026 12:51:04 PM
- 24/7 Market News: Kraig Labs the Bootstrapped Unicorn in the Making • GlobeNewswire Inc. • 03/11/2026 01:15:00 PM
- Washington’s Textile Strategy: How DPA Title III Could Strengthen U.S. Manufacturing and Defense Supply Chains • GlobeNewswire Inc. • 03/05/2026 03:05:00 PM
- Kraig Biocraft Laboratories Targets New Industrial and Defense Biomaterials as "Project Atlas" Hits Major Milestone • GlobeNewswire Inc. • 03/05/2026 12:05:00 PM
- Defense Supply Chains and Strategic Materials Drive the Morning Bid • GlobeNewswire Inc. • 03/03/2026 02:51:45 PM
- Follow-Through Leaders: Production Ramps, AI Alliances, Balance Sheet Strength • GlobeNewswire Inc. • 02/27/2026 02:45:46 PM
- Biotech and Big Tech Drive the Morning Narrative • GlobeNewswire Inc. • 02/24/2026 03:17:14 PM
- 24/7 Market News- “Somewhere in Michigan”: National Geographic Spotlights Kraig Biocraft Laboratories Science Powering Recombinant Spider Silk Production • GlobeNewswire Inc. • 02/24/2026 01:05:00 PM
- Biotech Breakthroughs, Big Buyouts, Immunotherapy Momentum, and a Media Megamerger • GlobeNewswire Inc. • 02/23/2026 02:36:14 PM
- Kraig Biocraft Laboratories’ Spider Silk Advancements Featured as the Cover of National Geographic's March 2026 Issue • GlobeNewswire Inc. • 02/23/2026 12:05:00 PM
- $30M Revenue Rocket, Super Spiders, and Biotech Patent Blitz Launch Morning Momentum • GlobeNewswire Inc. • 02/19/2026 04:00:26 PM
